Kilitch Drugs (India) Top Insiders

KILITCH Stock   310.65  3.25  1.06%   
Kilitch Drugs employs about 168 people. The company is managed by 8 executives with a total tenure of roughly 392 years, averaging almost 49.0 years of service per executive, having 21.0 employees per reported executive. Assessment of Kilitch Drugs' management performance can provide insight into the firm performance.
Mukund Mehta  Executive
Executive MD
Bhavin BPharm  Director
Wholetime Director
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kilitch Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Kilitch Drugs Management Team Effectiveness

The company has return on total asset (ROA) of 0.0566 % which means that it generated a profit of $0.0566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0832 %, meaning that it generated $0.0832 on every $100 dollars invested by stockholders. Kilitch Drugs' management efficiency ratios could be used to measure how well Kilitch Drugs manages its routine affairs as well as how well it operates its assets and liabilities. The current Total Assets is estimated to decrease to about 1.7 B. The current Non Current Assets Total is estimated to decrease to about 749.4 M
The Kilitch Drugs' current Net Income Applicable To Common Shares is estimated to increase to about 126.2 M, while Common Stock Shares Outstanding is projected to decrease to under 15.4 M.

Kilitch Drugs Workforce Comparison

Kilitch Drugs Limited is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 42,967. Kilitch Drugs adds roughly 168 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02.

Kilitch Drugs Limited Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Kilitch Drugs Limited Price Series Summation is a cross summation of Kilitch Drugs price series and its benchmark/peer.

Kilitch Drugs Notable Stakeholders

A Kilitch Drugs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kilitch Drugs often face trade-offs trying to please all of them. Kilitch Drugs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kilitch Drugs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Bhavin BPharmWholetime DirectorProfile
Tajouddin AnsariVPMarketing OperationProfile
Mira MehtaManaging DirectorProfile
Mukund MehtaExecutive MDProfile
LLB BComExecutive MDProfile
Sunil JainChief OfficerProfile
Pushpa NyoupaneCompany OfficerProfile
Rajesh KhatriGeneral AdministrationProfile

About Kilitch Drugs Management Performance

The success or failure of an entity such as Kilitch Drugs Limited often depends on how effective the management is. Kilitch Drugs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kilitch management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kilitch management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Kilitch Drugs is entity of India. It is traded as Stock on NSE exchange.

Kilitch Drugs Workforce Analysis

Traditionally, organizations such as Kilitch Drugs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kilitch Drugs within its industry.

Kilitch Drugs Manpower Efficiency

Return on Kilitch Drugs Manpower

Revenue Per Employee9.2M
Revenue Per Executive193M
Net Income Per Employee1.2M
Net Income Per Executive24.2M
Working Capital Per Employee4.9M
Working Capital Per Executive102.2M

Complementary Tools for Kilitch Stock analysis

When running Kilitch Drugs' price analysis, check to measure Kilitch Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kilitch Drugs is operating at the current time. Most of Kilitch Drugs' value examination focuses on studying past and present price action to predict the probability of Kilitch Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kilitch Drugs' price. Additionally, you may evaluate how the addition of Kilitch Drugs to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins